Science & Technology Review
|
2020, 38(1): 77-81
• Exclusive: Science and Technology Review in 2019 •
Hotspots of new antitumor drugs in 2019
Full
SHI Yuankai, SUN Yan
Affiliations
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China
Published: 2020-01-13
doi: 10.3981/j.issn.1000-7857.2020.01.006
Outline
The research and development of new anti-tumor drugs is the key field of new drug research and development. In recent years, with the support of national policies and the sustainable development of economy and society, China's ability to independently develop new anti-tumor drugs has been continuously improved. In 2019, some new domestic anti-tumor drugs were used clinically, providing more treatment options for patients. In this paper, we review the research results of some new antitumor drugs launched in 2019 market.
tumour
/
internal medicine treatment
/
new anti-tumor drugs
石远凯, 孙燕.
2019年抗肿瘤新药研发热点回眸.
科技导报,
2020
, 38
(1)
: 77
-81
.
DOI: 10.3981/j.issn.1000-7857.2020.01.006
SHI Yuankai, SUN Yan.
Hotspots of new antitumor drugs in 2019[J].
Science & Technology Review,
2020
, 38
(1)
: 77
-81
.
DOI: 10.3981/j.issn.1000-7857.2020.01.006
Year 2020 volume 38 Issue 1
PDF
468
110
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2020.01.006
- Receive Date:2020-01-02
- Online Date:2020-02-29
- Published:2020-01-13